Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenografts.

International journal of oncology

Volumn 20, Issue 2, 2002, Pages 379-384

  Modrak, David E ^a   Rodriguez, Marisol D ^a   Goldenberg, David M ^a   Lew, Walter ^a   Blumenthal, Rosalyn D ^a  

^a GARDEN STATE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 FU CDDP PROTOCOL; 5-FU-CDDP PROTOCOL; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CISPLATIN; DRUG DERIVATIVE; FLUOROURACIL; IRINOTECAN; SPHINGOMYELIN;

ANIMAL; APOPTOSIS; ARTICLE; CANCER TRANSPLANTATION; CELL CULTURE; COLON TUMOR; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; MOUSE; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; TIME; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CAMPTOTHECIN; CISPLATIN; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; FEMALE; FLUOROURACIL; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION; SPHINGOMYELINS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0036479901     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.20.2.379     Document Type: Article

References (0)